ETPrime

Genomic Valley Biotech Share Price

  • 66.201.20 (1.84%)
  • Volume: 37,893
BSE
  • Closed
  • Last Updated On: 30 Aug, 2024, 03:15 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Genomic Valley Biotech ...

  • 66.201.20 (1.84%)
  • Volume: 37,893
Advertisment

Genomic Valley Biotech share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 22.71% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Genomic Valley Biotech Ltd. share price moved up by 1.84% from its previous close of Rs 65.00. Genomic Valley Biotech Ltd. stock last traded price is 66.20

    Share PriceValue
    Today/Current/Last-66.20
    Previous Day-65.00

InsightsGenomic Valley Biotech

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		158.01
    EPS - TTM
    (₹)    		0.42
    MCap
    (₹ Cr.)    		20.22
    Sectoral MCap Rank
    		192
    PB Ratio
    (x)    		5.60
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		65.96
    52W H/L
    (₹)
    66.20 / 21.00

    Genomic Valley Biotech Share Price Returns

    1 Day1.84%
    1 Week5.92%
    1 Month24.91%
    3 Months71.28%
    1 Year194.22%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Genomic Valley Biotech belongs to analysts' top-rated companies list?

    View Stock Screeners

    Genomic Valley Biotech News & Analysis

    View all Genomic Valley Biotech Share News & Announcements

    Genomic Valley Biotech Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Genomic Valley Biotech Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Genomic Valley Biotech Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 22.71% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income0.160.000.040.070.06
      Total Income Growth (%)--100.00-42.2412.44-94.04
      Total Expenses0.030.040.020.040.03
      Total Expenses Growth (%)-37.89158.70-61.0933.3019.01
      EBIT0.13-0.040.020.020.03
      EBIT Growth (%)--304.96-6.25-13.43-97.26
      Profit after Tax (PAT)0.13-0.040.020.020.03
      PAT Growth (%)--304.96-6.25-13.43-97.26
      EBIT Margin (%)82.16-55.7934.3844.65
      Net Profit Margin (%)82.16-55.7934.3844.65
      Basic EPS (₹)0.42-0.150.070.080.09
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue0.172.770.150.210.86
      Total Revenue Growth (%)-93.971,688.86-26.74-75.48-13.92
      Total Expenses0.151.850.580.710.65
      Total Expenses Growth (%)-91.82221.84-19.288.84-14.40
      Profit after Tax (PAT)0.020.65-0.01-0.560.29
      PAT Growth (%)-97.66---295.4823.01
      Operating Profit Margin (%)9.2033.54-535.97-155.8845.55
      Net Profit Margin (%)9.2023.81-13.23-268.6733.78
      Basic EPS (₹)0.052.12-0.03-1.830.94

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets4.334.423.807.628.01
      Total Assets Growth (%)-2.0416.32-50.13-4.8711.56
      Total Liabilities0.790.890.923.132.96
      Total Liabilities Growth (%)-11.24-3.26-70.615.7422.31
      Total Equity3.543.532.884.495.05
      Total Equity Growth (%)0.2822.57-35.86-11.096.09
      Current Ratio (x)3.682.895.310.190.53
      Total Debt to Equity (x)0.000.170.000.340.29
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities-0.02-0.78-2.131.480.44
      Net Cash used in Investing Activities-0.021.523.67-1.58-0.47
      Net Cash flow from Financing Activities--0.70-1.550.07-
      Net Cash Flow-0.040.04-0.01-0.03-0.04
      Closing Cash & Cash Equivalent0.000.040.000.010.04
      Closing Cash & Cash Equivalent Growth (%)-94.461,441.91-76.61-69.66-49.70
      Total Debt/ CFO (x)0.00-0.780.001.043.38

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)0.4218.38-0.32-12.455.66
      Return on Capital Employed (%)0.4225.89-10.55-4.805.32
      Return on Assets (%)0.3514.66-0.24-7.333.57
      Interest Coverage Ratio (x)0.000.00-6.89-1.832.14
      Asset Turnover Ratio (x)0.040.660.012.7310.57
      Price to Earnings (x)714.2910.26-833.33-12.909.26
      Price to Book (x)2.991.882.631.610.52
      EV/EBITDA (x)650.077.83-25.72-64.707.24
      EBITDA Margin (%)9.8733.83-416.43-64.9466.64

      No reported Financial Ratios are available.

    Financial InsightsGenomic Valley Biotech

    • Income (P&L)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 22.71% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Genomic Valley Biotech Peer Comparison

    • Genomic Valley Biotech Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • There’s no suggested peer for this stock.
          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Genomic Valley Biotech158.015.710.420.420.35-7.509.209.200.053.680.000.00
          Add More stocks of your interest to compare.
          Annual Ratios (%)

          Choose from Peers

            Choose from Stocks

              See All Parameters

            Peers InsightsGenomic Valley Biotech

              Do you find these insights useful?

              • hate it

              • meh

              • love it

              Genomic Valley Biotech Shareholding Pattern

              • QOQ Change

              • Total Shareholdings

              • Loading...
                Showing Genomic Valley Biotech Shareholding as on 30 Jun 2024
                Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
                Promoters64.1464.2065.0466.32
                Pledge0.000.000.000.00
                FII0.000.000.000.00
                DII0.000.000.000.00
                Mutual Funds0.000.000.000.00
                Others35.8635.8034.9533.68
              • Showing Shareholding as on 30 Jun 2024
                CategoryNo. of SharesPercentage% Change QoQ
                Promoters19,59,05364.14 %-0.06
                Pledge00.00 %0.00
                Others10,95,44735.86 %0.06

              MF Ownership

              MF Ownership details are not available.

              Top Searches:

              Genomic Valley Biotech News Genomic Valley Biotech Quarterly Results Genomic Valley Biotech Dividend Genomic Valley Biotech Q1 ResultsGenomic Valley Biotech Q2 ResultsGenomic Valley Biotech Q3 ResultsGenomic Valley Biotech Q4 Results

              Corporate Actions

              • Genomic Valley Biotech Board Meeting/AGM

              • Genomic Valley Biotech Dividends

              • Others
              • Meeting DateAnnounced onPurposeDetails
                Jul 29, 2024Jul 23, 2024Board MeetingQuarterly Results
                May 09, 2024May 03, 2024Board MeetingAudited Results
                Feb 14, 2024Feb 10, 2024Board MeetingQuarterly Results
                Feb 10, 2024Feb 10, 2024Board MeetingQuarterly Results
                Nov 14, 2023Nov 08, 2023Board MeetingQuarterly Results

              • Dividend announcements are not available.

              • No other corporate actions details are available.

              About Genomic Valley Biotech

              Genomic Valley Biotech Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 19.85 Crore) operating in Miscellaneous sector. Genomic Valley Biotech Ltd. key Products/Revenue Segments include Cut Flowers for the year ending 31-Mar-2023. Show More

              • Executives

              • Auditors

              • YA

                Yogesh Agrawal

                Managing Director
                PA

                Parul Agrawal

                Non Executive Director
                JB

                Jyoti Bansal

                Ind. Non-Executive Director
                PK

                Praveen Kumar Mishara

                Ind. Non-Executive Director
                Show More
              • Andros & Co
                A K Khattar & Associates

              Industry

              Miscellaneous - Others

              Key Indices Listed on

              -

              Address

              4KM Stone,Berry Charra Road,Jhajjar District, Haryana - 124507

              Contact

              [email protected]

              http://www.genomicvalley.com

              More Details

              Trending in Markets

              DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

              DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

              By using this site, you agree to the Terms of Service and Privacy Policy.

              Business News›Markets›Stocks›Stock Price Quotes›Genomic Valley Biotech Share Price
              The Economic Times